Tradestie Institutional Equity Comparison Engine
VVOS vs ABLLL โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ABLLL Overall Edge
ABLLL Captures Institutional Edge (3โ0 Pillars ยท 6โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Abacus Global Management, Inc. 9.875% Fixed Rate Senior Notes due 2028 (ABLLL) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, VVOS trades at N/M Forward P/E with -107.9% operating margin (+34.9% YoY revenue) versus ABLLL at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, VVOS sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against ABLLL sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
VVOS N/M vs ABLLL N/M Fwd P/E
Growth & Margin Winner
ABLLL
Op Margin -107.9% vs 0.0% ยท YoY +34.9% vs +0.0%
Momentum & Technical Winner
ABLLL
1Y -97.7% vs -6.3% ยท 52W Pos 0% vs 28%
Options & Structure Winner
ABLLL
BREAKDOWN (N/A IV) vs UNCLASSIFIED (N/A IV)
VVOS
NASDAQ
Vivos Therapeutics, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$0.05
-5.1% 1D
Market Cap
$1.9M
1M Return
-59.25%
1Y Return
-97.71%
Forward P/E
N/M
Unified AI Score
36.4 / 100
SELL
Tech 25.0
Fund 35.0
Flow 50.0
Mom 30.0
ABLLL
NASDAQ
Abacus Global Management, Inc. 9.875% Fixed Rate Senior Notes due 2028
Investment Advice
$25.46
+0.24% 1D
Market Cap
N/A
1M Return
+0.75%
1Y Return
-6.33%
Forward P/E
N/M
Unified AI Score
62.5 / 100
BUY
Tech 75.0
Fund 60.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
VVOS -97.71%
ABLLL -6.33%
Spread: +15.71 pp (ABLLL Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
VVOS TTM Op. Margin: -107.9%
ABLLL TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on VVOS vs ABLLL. Trailing 12-month operating profitability (VVOS -107.9% vs ABLLL 0.0%) and valuation multiples (VVOS N/M vs ABLLL N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | VVOS | ABLLL | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.9M | N/A | Larger Scale | VVOS |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +34.9% | +0.0% | Higher Growth | VVOS |
| Operating Margin (TTM) Profitability | -107.9% | 0.0% | Higher Margin | ABLLL |
| Net Profit Margin Profitability | -121.8% | 0.0% | Higher Margin | ABLLL |
| Return on Equity (ROE) Capital Efficiency | -8585.3% | 0.0% | Higher ROE | ABLLL |
| 52-Week Range Position Momentum | 0% ($0โ$3) | 28% ($21โ$38) | Stronger Trend | ABLLL |
| Beta / 30D Volatility Risk Regime | 1.70ฮฒ ยท 111% Vol | 0.08ฮฒ ยท 2% Vol | Lower Realized Risk | ABLLL |
| Unified Institutional Score Composite Signal | 36.4 / 100 (SELL) | 62.5 / 100 (BUY) | Higher Composite | ABLLL |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full VVOS vs ABLLL Buy Guide
VVOS
BREAKDOWN
113d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
ABLLL
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither VVOS nor ABLLL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.